Matches in SemOpenAlex for { <https://semopenalex.org/work/W2111650326> ?p ?o ?g. }
- W2111650326 endingPage "3560" @default.
- W2111650326 startingPage "3557" @default.
- W2111650326 abstract "Abstract Initial analysis of the Assessment of Proteasome Inhibition for Extending Remissions (APEX) trial of relapsed multiple myeloma patients showed significantly longer time to progression, higher response rate, and improved survival with single-agent bortezomib versus high-dose dexamethasone. In this updated analysis (median follow-up: 22 months), survival was assessed in both arms, and efficacy updated for the bortezomib arm. Median survival was 29.8 months for bortezomib versus 23.7 months for dexamethasone, a 6-month benefit, despite substantial crossover from dexamethasone to bortezomib. Overall and complete response rates with bortezomib were 43% and 9%, respectively; among responding patients, 56% improved response with longer therapy beyond initial response, leading to continued improvement in overall quality of response. Higher response quality (100% M-protein reduction) was associated with longer response duration; response duration was not associated with time to response. These data confirm the activity of bortezomib and support extended treatment in relapsed multiple myeloma patients tolerating therapy. This study is registered at http://clinicaltrials.gov (Study ID NCT00048230)." @default.
- W2111650326 created "2016-06-24" @default.
- W2111650326 creator A5002061358 @default.
- W2111650326 creator A5002972322 @default.
- W2111650326 creator A5018139001 @default.
- W2111650326 creator A5023276777 @default.
- W2111650326 creator A5029569818 @default.
- W2111650326 creator A5029801761 @default.
- W2111650326 creator A5031837957 @default.
- W2111650326 creator A5032464400 @default.
- W2111650326 creator A5034783996 @default.
- W2111650326 creator A5043490010 @default.
- W2111650326 creator A5043526996 @default.
- W2111650326 creator A5047235687 @default.
- W2111650326 creator A5047272364 @default.
- W2111650326 creator A5048985421 @default.
- W2111650326 creator A5056492087 @default.
- W2111650326 creator A5057834186 @default.
- W2111650326 creator A5057911528 @default.
- W2111650326 creator A5066940168 @default.
- W2111650326 creator A5071589084 @default.
- W2111650326 creator A5074839025 @default.
- W2111650326 creator A5076611748 @default.
- W2111650326 creator A5081233146 @default.
- W2111650326 creator A5087799564 @default.
- W2111650326 creator A5090790045 @default.
- W2111650326 date "2007-11-15" @default.
- W2111650326 modified "2023-10-17" @default.
- W2111650326 title "Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial" @default.
- W2111650326 cites W1970170167 @default.
- W2111650326 cites W1978377409 @default.
- W2111650326 cites W1992459906 @default.
- W2111650326 cites W2085806665 @default.
- W2111650326 cites W2107154392 @default.
- W2111650326 cites W2108235071 @default.
- W2111650326 cites W2124560610 @default.
- W2111650326 cites W2131915887 @default.
- W2111650326 cites W2145412346 @default.
- W2111650326 cites W2166043738 @default.
- W2111650326 cites W2222906927 @default.
- W2111650326 cites W2555212956 @default.
- W2111650326 cites W2568354557 @default.
- W2111650326 cites W2571500974 @default.
- W2111650326 cites W2580695821 @default.
- W2111650326 cites W2583215460 @default.
- W2111650326 cites W2586643383 @default.
- W2111650326 cites W2587631371 @default.
- W2111650326 cites W2591392246 @default.
- W2111650326 cites W68159190 @default.
- W2111650326 doi "https://doi.org/10.1182/blood-2006-08-036947" @default.
- W2111650326 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17690257" @default.
- W2111650326 hasPublicationYear "2007" @default.
- W2111650326 type Work @default.
- W2111650326 sameAs 2111650326 @default.
- W2111650326 citedByCount "484" @default.
- W2111650326 countsByYear W21116503262012 @default.
- W2111650326 countsByYear W21116503262013 @default.
- W2111650326 countsByYear W21116503262014 @default.
- W2111650326 countsByYear W21116503262015 @default.
- W2111650326 countsByYear W21116503262016 @default.
- W2111650326 countsByYear W21116503262017 @default.
- W2111650326 countsByYear W21116503262018 @default.
- W2111650326 countsByYear W21116503262019 @default.
- W2111650326 countsByYear W21116503262020 @default.
- W2111650326 countsByYear W21116503262021 @default.
- W2111650326 countsByYear W21116503262022 @default.
- W2111650326 countsByYear W21116503262023 @default.
- W2111650326 crossrefType "journal-article" @default.
- W2111650326 hasAuthorship W2111650326A5002061358 @default.
- W2111650326 hasAuthorship W2111650326A5002972322 @default.
- W2111650326 hasAuthorship W2111650326A5018139001 @default.
- W2111650326 hasAuthorship W2111650326A5023276777 @default.
- W2111650326 hasAuthorship W2111650326A5029569818 @default.
- W2111650326 hasAuthorship W2111650326A5029801761 @default.
- W2111650326 hasAuthorship W2111650326A5031837957 @default.
- W2111650326 hasAuthorship W2111650326A5032464400 @default.
- W2111650326 hasAuthorship W2111650326A5034783996 @default.
- W2111650326 hasAuthorship W2111650326A5043490010 @default.
- W2111650326 hasAuthorship W2111650326A5043526996 @default.
- W2111650326 hasAuthorship W2111650326A5047235687 @default.
- W2111650326 hasAuthorship W2111650326A5047272364 @default.
- W2111650326 hasAuthorship W2111650326A5048985421 @default.
- W2111650326 hasAuthorship W2111650326A5056492087 @default.
- W2111650326 hasAuthorship W2111650326A5057834186 @default.
- W2111650326 hasAuthorship W2111650326A5057911528 @default.
- W2111650326 hasAuthorship W2111650326A5066940168 @default.
- W2111650326 hasAuthorship W2111650326A5071589084 @default.
- W2111650326 hasAuthorship W2111650326A5074839025 @default.
- W2111650326 hasAuthorship W2111650326A5076611748 @default.
- W2111650326 hasAuthorship W2111650326A5081233146 @default.
- W2111650326 hasAuthorship W2111650326A5087799564 @default.
- W2111650326 hasAuthorship W2111650326A5090790045 @default.
- W2111650326 hasBestOaLocation W21116503261 @default.
- W2111650326 hasConcept C126322002 @default.
- W2111650326 hasConcept C141071460 @default.
- W2111650326 hasConcept C143998085 @default.
- W2111650326 hasConcept C2776364478 @default.
- W2111650326 hasConcept C2777478702 @default.